Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Besse

Showing results (21-30 of 511) with videos related to

Pageof 52
Sort By:
La Revue Du Praticien|April 26, 2007
[Treatment of cancer: surgery, radiotherapy, chemotherapy, hormonal therapy. Multidisciplinary therapeutic decision making and informing the patient]Benjamin Besse, Jean-Charles Soria
Translational Lung Cancer Research|July 23, 2021
Narrative review of immunotherapy in thymic malignanciesJose Carlos Benitez, Benjamin Besse
Bulletin Du Cancer|February 5, 2013
[Brain metastases of non small cell lung cancers: systemic treatments]Marie Chaubet-Houdu, Benjamin Besse
European Respiratory Review : an Official Journal of the European Respiratory Society|December 2, 2015
Second-line combination therapies in nonsmall cell lung cancer without known driver mutationsMaria-Virginia Bluthgen, Benjamin Besse
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2008
Adjuvant chemotherapy for non-small-cell lung cancer: a fading effect?Benjamin Besse, Thierry Le Chevalier
Presse Medicale (Paris, France : 1983)|September 4, 2013
Thymic tumours: an updateValentina Polo, Nicolas Girard, Benjamin Besse
European Respiratory Review : an Official Journal of the European Respiratory Society|September 2, 2014
New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of responseJessica Menis, Baktiar Hasan, Benjamin Besse
The European Respiratory Journal|May 2, 2016
The 5000% case: a glimpse into the financial issue of lung cancer treatmentJordi Remon, Julia Bonastre, Benjamin Besse
JAMA Oncology|November 19, 2020
Clarification of Definitions of Hyperprogressive Disease During Immunotherapy-ReplyCaroline Caramella, Roberto Ferrara, Benjamin Besse
The New England Journal of Medicine|April 10, 2024
Selpercatinib and Pseudo-Decreases in Kidney FunctionHassan Izzedine, Elise Bouderlique, Benjamin Besse
Pageof 52

Showing results (21-30 of 511) with videos related to

Sort By:
Pageof 52
La Revue Du Praticien|April 26, 2007
[Treatment of cancer: surgery, radiotherapy, chemotherapy, hormonal therapy. Multidisciplinary therapeutic decision making and informing the patient]Benjamin Besse, Jean-Charles Soria
Translational Lung Cancer Research|July 23, 2021
Narrative review of immunotherapy in thymic malignanciesJose Carlos Benitez, Benjamin Besse
Bulletin Du Cancer|February 5, 2013
[Brain metastases of non small cell lung cancers: systemic treatments]Marie Chaubet-Houdu, Benjamin Besse
European Respiratory Review : an Official Journal of the European Respiratory Society|December 2, 2015
Second-line combination therapies in nonsmall cell lung cancer without known driver mutationsMaria-Virginia Bluthgen, Benjamin Besse
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2008
Adjuvant chemotherapy for non-small-cell lung cancer: a fading effect?Benjamin Besse, Thierry Le Chevalier
Presse Medicale (Paris, France : 1983)|September 4, 2013
Thymic tumours: an updateValentina Polo, Nicolas Girard, Benjamin Besse
European Respiratory Review : an Official Journal of the European Respiratory Society|September 2, 2014
New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of responseJessica Menis, Baktiar Hasan, Benjamin Besse
The European Respiratory Journal|May 2, 2016
The 5000% case: a glimpse into the financial issue of lung cancer treatmentJordi Remon, Julia Bonastre, Benjamin Besse
JAMA Oncology|November 19, 2020
Clarification of Definitions of Hyperprogressive Disease During Immunotherapy-ReplyCaroline Caramella, Roberto Ferrara, Benjamin Besse
The New England Journal of Medicine|April 10, 2024
Selpercatinib and Pseudo-Decreases in Kidney FunctionHassan Izzedine, Elise Bouderlique, Benjamin Besse
Pageof 52